BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15264227)

  • 1. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
    Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
    J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease.
    Tortarolo M; Grignaschi G; Calvaresi N; Zennaro E; Spaltro G; Colovic M; Fracasso C; Guiso G; Elger B; Schneider H; Seilheimer B; Caccia S; Bendotti C
    J Neurosci Res; 2006 Jan; 83(1):134-46. PubMed ID: 16323214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis.
    Andries M; Van Damme P; Robberecht W; Van Den Bosch L
    Neurobiol Dis; 2007 Jan; 25(1):8-16. PubMed ID: 17045808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice.
    Turner BJ; Cheah IK; Macfarlane KJ; Lopes EC; Petratos S; Langford SJ; Cheema SS
    J Neurochem; 2003 Nov; 87(3):752-63. PubMed ID: 14535957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis.
    Patai R; Paizs M; Tortarolo M; Bendotti C; Obál I; Engelhardt JI; Siklós L
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1739-1748. PubMed ID: 28528135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
    Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
    Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
    Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
    Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis.
    Giribaldi F; Milanese M; Bonifacino T; Anna Rossi PI; Di Prisco S; Pittaluga A; Tacchetti C; Puliti A; Usai C; Bonanno G
    Neuropharmacology; 2013 Mar; 66():253-63. PubMed ID: 22634363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu2+/Zn2+ superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity.
    Johnson FO; Yuan Y; Hajela RK; Chitrakar A; Parsell DM; Atchison WD
    J Pharmacol Exp Ther; 2011 Aug; 338(2):518-27. PubMed ID: 21586603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis.
    Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
    Brain Res; 2007 May; 1148():234-42. PubMed ID: 17397813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx.
    Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S
    J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis.
    Caioli S; Curcio L; Pieri M; Antonini A; Marolda R; Severini C; Zona C
    Neurobiol Dis; 2011 Oct; 44(1):92-101. PubMed ID: 21726643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
    Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
    J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS.
    Chang Q; Martin LJ
    Neurobiol Dis; 2016 Sep; 93():78-95. PubMed ID: 27151771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
    Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
    Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Van Damme P; Leyssen M; Callewaert G; Robberecht W; Van Den Bosch L
    Neurosci Lett; 2003 Jun; 343(2):81-4. PubMed ID: 12759169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.